Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $610.00

Intuitive Surgical (NASDAQ:ISRG) had its price target lifted by Robert W. Baird from $575.00 to $610.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the medical equipment provider’s stock. Robert W. Baird’s price objective would indicate a potential upside of 24.74% from the stock’s previous close.

Several other brokerages also recently weighed in on ISRG. Truist Financial reduced their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Piper Sandler dropped their price target on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. dropped their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday. Argus dropped their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Finally, The Goldman Sachs Group boosted their price target on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $586.70.

Intuitive Surgical Stock Up 8.4%

Shares of ISRG stock traded up $37.73 during trading hours on Wednesday, hitting $489.02. 1,227,343 shares of the company’s stock were exchanged, compared to its average volume of 1,936,641. The firm has a market cap of $173.66 billion, a P/E ratio of 61.89, a P/E/G ratio of 3.64 and a beta of 1.68. The firm has a 50 day moving average of $477.79 and a two-hundred day moving average of $515.63. Intuitive Surgical has a fifty-two week low of $427.84 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.81 EPS. On average, equities analysts forecast that Intuitive Surgical will post 8.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This represents a 28.57% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The SEC filing for this sale provides additional information. Insiders have sold 32,943 shares of company stock valued at $17,279,568 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

Large investors have recently added to or reduced their stakes in the stock. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. grew its holdings in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat — ISRG reported $2.50 EPS vs. ~$2.08 expected and $2.77B in revenue (up ~23% year-over-year), driven by robust demand for its robotic systems. Intuitive Surgical beats quarterly expectations on surgical robot demand (Reuters)
• Positive Sentiment: Raised procedure outlook — Management increased its 2026 da Vinci procedure growth guidance to roughly 13.5%–15.5% and noted expanding Force Feedback availability, signaling continued market adoption. Intuitive forecasts 13.5%-15.5% 2026 da Vinci procedure growth (Seeking Alpha)
• Positive Sentiment: Procedure mix strength — Worldwide procedures (da Vinci +16%, Ion +39%) and placements contributed to broad-based growth across general surgery and oncology, supporting long-term revenue drivers. Intuitive Announces First Quarter Earnings (GlobeNewswire)
• Positive Sentiment: Analyst support — Several firms reaffirm Buy ratings (BTIG, Truist and others) following results, leaving upside potential tied to execution and procedure adoption. BTIG reaffirms buy; coverage notes (TickerReport/Benzinga)
• Neutral Sentiment: Product & innovation progress — Management highlighted digital initiatives and broader availability of features (e.g., Force Feedback); these are strategic positives but will affect revenue gradually. Q1 highlights and digital innovation (Yahoo Finance)
• Negative Sentiment: Price-target cuts and cautious notes — TD Cowen cut its PT to $585 (from $660) while others trimmed targets ahead/of the print, which caps near-term upside. TD Cowen lowers PT to $585 (TipRanks)
• Negative Sentiment: Market reaction & valuation concerns — Despite the beat and a modest guide lift, the stock sold off after hours as investors parsed conservative commentary, international headwinds and valuation (calls to “not overpay”). Why Intuitive dropped despite beat (Yahoo Finance)

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.